查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
診斷酵素市場規模,份額和趨勢分析報告：按類型（Taq聚合酵素,MMLV RT,HIV RT）,應用（糖尿病,腫瘤學,心臟病學）,產品類型,地區,細分市場預測2022-2030
市場調查報告書
商品編碼
1171027

診斷酵素市場規模,份額和趨勢分析報告：按類型（Taq聚合酵素,MMLV RT,HIV RT）,應用（糖尿病,腫瘤學,心臟病學）,產品類型,地區,細分市場預測2022-2030

Diagnostic Enzymes Market Size, Share & Trends Analysis Report By Type (Taq Polymerase, MMLV RT, HIV RT), Application (Diabetes, Oncology, Cardiology), Product Type, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10個工作天內

價格

診斷酵素市場增長和趨勢

根據 Grand View Research, Inc. 的一份新報告，到 2030 年，全球診斷酵素市場規模預計將達到 62.6 億美元，預測期內的複合年增長率為 3.97%。診斷酵素市場的增長歸因於對廣泛應用於病理學的診斷酵素的需求不斷增長。此外，病毒感染診斷技術的進步有望推動市場增長。

由於酵素活性提供的高靈敏度和精確度，診斷酵素被廣泛採用。可以比臨床症狀和其他診斷指標更早地檢測到酵素活性。生物傳感器作為醫學診斷、病原體檢測和監測的潛在工具正變得越來越流行。生物傳感器因其準確性、靈敏度、選擇性和可以常規使用的快速檢測策略而受到歡迎。酵素血清水平的診斷已被用作導致細胞間成分釋放到血流中的細胞毒性的指標。

呼吸道病毒感染是最常見的人類疾病之一，而以COVID-19為代表的新發病毒爆發引起的疾病對公眾健康構成威脅。因此，病毒病原體的檢測對於阻止此類流行病的爆發和防止不必要的抗生素使用至關重要。因此，主要參與者正在採用新的診斷策略。LightMix（Roche Molecular Diagnostics, Switzerland）, AccuPower（Bioneer, Korea）, PowerChek（Kogene Biotech, Korea）, Anyplex（Seegene, Korea）, UltraFast kits（Nanobiosys, Korea）, and DiaPlexQ（SolGent, Korea）的靈敏度為99.03%，是用於 MERS-CoV RNA 檢測的商用 RT-PCR 試劑盒的一部分。

越來越多的診斷酵素測試導致了關於其性能的大量論文以及越來越多的建議和指南。此外，報銷渠道缺乏明確的指南和系統的衛生技術評估（HTA）。影響診斷酵素測試付款人決定的因素包括 FDA 批准、醫生支持和臨床指南、競爭對手覆蓋政策、成本/收益分析、HTA 結果、雇主和倡導團體等。

此外，市場上的主要參與者正專注於擴展和推出可用於廣泛應用的產品。例如，2022 年 3 月，Meridian Biosciences 推出了兩款可用於無創液體活檢的預混液。與傳統的純化核酸 qPCR 相比，這種突破性技術的推出將能夠更好地分析性能水平。

診斷酵素市場報告亮點

到 2021 年，由於生物體內大量存在酵素，葡萄糖氧化酵素/葡萄糖脫氫酵素細分市場將佔據主導地位。

由於癌症患病率的增加，預計腫瘤學領域在預測期內將以最快的速度增長

對研發的重視將使臨床領域成為2021年利潤最高的領域。

主要市場參與者的存在正在改變診斷酵素市場，主要市場參與者專注於產品發布和地域擴張以保持其市場地位。

由於製造設施的改善和目標人群的存在，預計亞太地區在預測期內增長最快。

目錄

第一章 調查方法和範圍

  • 市場細分
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • 次要信息
    • 初步調查
    • 初步調查詳情
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法一：商品流動方法
      • 方法 2：使用自下而上的方法進行國別市場估算
  • 全球市場：複合年增長率計算
  • 調查假設
  • 二級信息列表
  • 主要信息列表
  • 目的
  • 縮略語表

第二章執行摘要

  • 市場概況

3 診斷酵素市場變量、趨勢和範圍

  • 診斷酵素市場譜系展望
    • 母公司市場展望
    • 輔助市場展望-體外診斷（IVD）市場
  • 繪製滲透率和增長前景
  • 市場動態
  • 市場驅動力分析
    • 診斷中對酵素的需求不斷增加
    • 酵素在病理學中的廣泛應用
    • 病毒感染診斷檢測的進展
    • 對 POC 測試的需求增加
  • 市場約束因素分析
    • 基於酵素的診斷測試成本高
    • 酵素促診斷監管和報銷障礙
  • SWOT分析：按因素（政法、經濟、技術）
  • 波特五力分析

4 診斷酵素市場：細分分析，按類型，2018-2030

  • 診斷酵素市場：按類型的變化分析
    • Taq聚合酵素
    • MMLVRT
    • 艾滋病抗逆轉錄病毒
    • 熱啟動 Taq Pol
    • 聯合國
    • 核糖核酸酵素抑製劑
    • Bst 聚合酵素（LAMP 酵素）
    • PCR 預混液
    • 凍乾聚合酵素
    • T7 RNA聚合酵素
    • Cas9酵素
    • 酸性磷酸酵素
    • 谷丙轉氨酵素
    • 鹼性磷酸酵素
    • 澱粉酵素
    • 血管緊張素轉換酵素
    • 天冬氨酸氨基轉移酵素
    • 膽鹼酯酵素
    • 肌酐激酵素
    • γ谷氨□轉移酵素
    • 乳酸脫氫酵素
    • 腎素
    • 葡萄糖氧化酵素/葡萄糖脫氫酵素
    • 尿酵素
    • 乳酸氧化酵素
    • 過氧化辣根
    • 谷氨酸氧化酵素
    • 其他

5 診斷酵素市場：細分分析，按應用，2018-2030

  • 診斷酵素市場：應用變化分析
    • 糖尿病
    • 腫瘤學
    • 心髒病學
    • 感染
    • 腎臟科
    • 自身免疫性疾病
    • 其他

6 診斷酵素市場：細分分析，按產品類型，2018-2030

  • 診斷酵素市場：按產品類型的變化分析
    • 分子酵素
    • 臨床酵素

7. 診斷酵素市場：2018-2030 年按地區細分分析

  • 診斷酵素市場：按地區劃分的變化分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
  • 亞太地區
    • 日本
    • 中國
    • 印度
  • 世界其他地區
    • 巴西
    • 南非

8 診斷酵素市場：競爭分析

  • 近期發展和影響分析：按主要市場進入者
    • 安索夫矩陣
    • 重大交易及戰略聯盟分析
      • 市場拓展
      • 產品發布會
      • 獲得
      • 夥伴關係和協作
  • 公司分類
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要經銷商及渠道合作夥伴名單
    • 主要客戶
    • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 公司市場分析
    • 熱圖分析
    • 區域網絡圖
    • 競爭儀錶盤分析
      • 市場差異化因素
  • 民營企業
    • 主要初創企業名單
    • 熱圖分析
    • 區域網絡圖

第九章公司簡介

  • Takara Bio, Inc.
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Promega Corporation
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Enzo Life Sciences, Inc.
    • 公司簡介
    • 產品基準
  • Merck KGaA
    • 公司簡介
      • Sigma-Aldrich Co., Ltd.
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Thermo Fisher Scientific, Inc.
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Creative Enzymes
    • 公司簡介
    • 產品基準
  • F. Hoffmann-La Roche Ltd.
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
  • Solis BioDyne
    • 公司簡介
    • 財務績效
    • 產品基準
  • Ampliqon A/S
    • 公司簡介
    • 財務績效
    • 產品基準
    • 戰略舉措
Product Code: GVR-4-68040-003-4

Diagnostic Enzymes Market Growth & Trends:

The global diagnostic enzymes market size is expected to reach USD 6.26 billion by 2030, registering a CAGR of 3.97% during the forecast period, according to a new report by Grand View Research, Inc.Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Diagnostic Enzymes Market Report Highlights:

  • In 2021, the glucose oxidase/glucose dehydrogenase enzyme segment held a dominant share in the market owing to the presence of an abundance of enzymes in living organisms
  • The oncology segment is projected to grow at the fastest rate during the forecast period owing to the increasing prevalence of cancer among the population
  • The clinical segment is the highest revenue-generating segment in 2021 owing to the increased focus on R&D
  • The diagnostic enzyme market is witnessing change owing to the presence of key market players focusing on product launches and geographic expansion to maintain their position in the market
  • Asia Pacific is expected to witness the fastest growth during the forecast period owing to the improved manufacturing facilities and the presence of the target population

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Secondary Sources
    • 1.3.3 Primary Research
    • 1.3.4 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise Market Estimation Using Bottom-Up Approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
  • 1.12 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Diagnostic Enzymes Market Variables, Trends, & Scope

  • 3.1 Diagnostic Enzymes Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook - In Vitro Diagnostics (IVD) Market
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
  • 3.4 Market Driver Analysis
    • 3.4.1 Rise in the demand for enzymes in diagnostics
    • 3.4.2 Wide applications of enzymes in pathology
    • 3.4.3 Advancements in diagnostic testing of viral infections
    • 3.4.4 Increase in the demand for Point-of-Care testing
  • 3.5 Market Restraint Analysis
    • 3.5.1 High cost of enzyme-based diagnostic tests
    • 3.5.2 Regulatory & reimbursement hurdles for enzyme diagnostics
  • 3.6 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 3.7 Porter's Five Forces Analysis

Chapter 4 Diagnostic Enzymes Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 Diagnostic Enzymes Market: Type Movement Analysis
    • 4.1.1 Taq Polymerase
      • 4.1.1.1 Taq Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.2 MMLV RT
      • 4.1.2.1 MMLV RT Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.3 HIV RT
      • 4.1.3.1 HIV RT Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.4 Hot Start Taq Pol
      • 4.1.4.1 Hot Start Taq Pol Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.5 UNG
      • 4.1.5.1 UNG Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.6 Rnase Inhibitors
      • 4.1.6.1 Rnase Inhibitors Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.7 Bst Polymerase (LAMP Enzyme)
      • 4.1.7.1 Bst Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.8 PCR Master Mix
      • 4.1.8.1 PCR Master Mix Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.9 Lyophilized Polymerase
      • 4.1.9.1 Lyophilized Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.10 T7 RNA Polymerase
      • 4.1.10.1 T7 RNA Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.11 Cas9 Enzyme
      • 4.1.11.1 Cas9 Enzyme Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.12 Acid Phosphatase
      • 4.1.12.1 Acid Phosphatase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.13 Alanine Aminotransferase
      • 4.1.13.1 Alanine Aminotransferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.14 Alkaline Phosphatase
      • 4.1.14.1 Alkaline Phosphatase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.15 Amylase
      • 4.1.15.1 Amylase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.16 Angiotensin Converting Enzyme
      • 4.1.16.1 Angiotensin Converting Enzyme Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.17 Aspartate Aminotransferase
      • 4.1.17.1 Aspartate Aminotransferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.18 Cholinesterase
      • 4.1.18.1 Cholinesterase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.19 Creatinine Kinase
      • 4.1.19.1 Creatinine Kinase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.20 Gamma Glutamyl Transferase
      • 4.1.20.1 Gamma Glutamyl Transferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.21 Lactate Dehydrogenase
      • 4.1.21.1 Lactate Dehydrogenase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.22 Renin
      • 4.1.22.1 Renin Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.23 Glucose Oxidase/Glucose Dehydrogenase
      • 4.1.23.1 Glucose Oxidase/Glucose Dehydrogenase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.24 Urease
      • 4.1.24.1 Urease Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.25 Lactate Oxidase
      • 4.1.25.1 Lactate Oxidase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.26 Horseradish Peroxide
      • 4.1.26.1 Horseradish Peroxide Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.27 Glutamate Oxidase
      • 4.1.27.1 Glutamate Oxidase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.28 Others
      • 4.1.28.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Diagnostic Enzymes Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1 Diagnostic Enzymes Market: Application Movement Analysis
    • 5.1.1 Diabetes
      • 5.1.1.1 Diabetes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.2 Oncology
      • 5.1.2.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.3 Cardiology
      • 5.1.3.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.4 Infectious Diseases
      • 5.1.4.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.5 Nephrology
      • 5.1.5.1 Nephrology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.6 Autoimmune Diseases
      • 5.1.6.1 Autoimmune Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.7 Others
      • 5.1.7.1 Others Market Estimates And Forecast, 2017-2030, USD Million

Chapter 6 Diagnostic Enzymes Market - Segment Analysis, By Product Type, 2018 - 2030 (USD Million)

  • 6.1 Diagnostic Enzymes Market: Product Type Movement Analysis
    • 6.1.1 Molecular Enzymes
      • 6.1.1.1 Molecular Enzymes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.1.2 Clinical Enzymes
      • 6.1.2.1 Clinical Enzymes Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Diagnostic Enzymes Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 7.1 Diagnostic Enzymes Market: Regional Movement Analysis
  • 7.2 North America
    • 7.2.1 North America Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 UK Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.5 Rest of World
    • 7.5.1 Rest of World Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.5.3 South Africa
      • 7.5.3.1 South Africa Diagnostic Enzymes Market, 2018 - 2030 (USD Million)

Chapter 8 Diagnostic Enzymes Market: Competitive Analysis

  • 8.1 Recent developments and impact analysis, by key market participants
    • 8.1.1 Ansoff Matrix
    • 8.1.2 Major Deals And Strategic Alliances Analysis
      • 8.1.2.1 Market Expansion
      • 8.1.2.2 Product Launch
      • 8.1.2.3 Acquisition
      • 8.1.2.4 Partnerships and Collaborations
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List Of Key Distributors And Channel Partners
    • 8.3.2 Key Customers
    • 8.3.3 Key Company Market Share Analysis, 2021
  • 8.4 Public Companies
    • 8.4.1 Company Market Position Analysis
    • 8.4.2 Heat Map Analysis
    • 8.4.3 Regional Network Map
    • 8.4.4 Competitive Dashboard Analysis
      • 8.4.4.1 Market Differentiators
  • 8.5 Private Companies
    • 8.5.1 List Of Key Emerging Companies
    • 8.5.2 Heat Map Analysis
    • 8.5.3 Regional Network Map

Chapter 9 Company Profiles

  • 9.1 Takara Bio, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Benchmarking
    • 9.1.4 Strategic Initiatives
  • 9.2 Promega Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Benchmarking
    • 9.2.4 Strategic Initiatives
  • 9.3 Enzo Life Sciences, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Product Benchmarking
  • 9.4 Merck KGaA
    • 9.4.1 Company Overview
      • 9.4.1.1 Sigma-Aldrich Co. Llc
    • 9.4.2 Financial Performance
    • 9.4.3 Product Benchmarking
    • 9.4.4 Strategic Initiatives
  • 9.5 Thermo Fisher Scientific, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Benchmarking
    • 9.5.4 Strategic Initiatives
  • 9.6 Creative Enzymes
    • 9.6.1 Company Overview
    • 9.6.2 Product Benchmarking
  • 9.7 F. Hoffmann-La Roche Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Benchmarking
    • 9.7.4 Strategic Initiatives
  • 9.8 Solis BioDyne
    • 9.8.1 Company Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Benchmarking
  • 9.9 Ampliqon A/S
    • 9.9.1 Company Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Benchmarking
    • 9.9.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global diagnostic enzymes market, by region, 2018 - 2030 (USD Million)
  • TABLE 5 Global diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 6 Global diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 7 Global diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 8 North America diagnostic enzymes market, by country, 2018 - 2030 (USD Million)
  • TABLE 9 North America diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 10 North America diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 11 North America diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 12 U.S. diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 15 Canada diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 16 Canada diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 17 Canada diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 18 Europe diagnostic enzymes market, 2018 - 2030 (USD Million)
  • TABLE 19 Europe diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 20 Europe diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 21 Europe diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 22 UK diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 23 UK diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 24 UK diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 25 Germany diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 26 Germany diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 27 Germany diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 28 France diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 29 France diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 30 France diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 31 Asia Pacific diagnostic enzymes market, 2018 - 2030 (USD Million)
  • TABLE 32 Asia Pacific diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 33 Asia Pacific diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 34 Asia Pacific diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 35 Japan diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 36 Japan diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 37 Japan diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 38 China diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 39 China diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 40 China diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 41 India market, by type, 2018 - 2030 (USD Million)
  • TABLE 42 India diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 43 India diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 44 Rest of Worlddiagnostic enzymes market, 2018 - 2030 (USD Million)
  • TABLE 45 Rest of Worlddiagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 46 Rest of Worlddiagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 47 Rest of Worlddiagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 48 Brazil diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 49 Brazil diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 50 Brazil diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 51 South Africa diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 52 South Africa diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 53 South Africa diagnostic enzymes market, by application, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Diagnostic enzymes market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Diagnostic enzymes market snapshot
  • FIG. 10 Penetration and growth prospect mapping for application, 2021 (USD Million)
  • FIG. 11 Market Dynamics
  • FIG. 12 Diagnostic enzymes market driver impact
  • FIG. 13 Enzymes in the diagnosis of diseases
  • FIG. 14 Common applications of enzymes in pathology
  • FIG. 15 Diagnostic enzymes market restraint impact
  • FIG. 16 Porter's five forces analysis
  • FIG. 17 Diagnostic enzymes market: Type outlook and key takeaways
  • FIG. 18 Common diagnostic enzymes
  • FIG. 19 Taq polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 20 MMLV-RT market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 21 HIV RT market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 22 Evaluation Index of Antibody Modified Hot Start Taq DNA Polymerase
  • FIG. 23 Hot start Taq pol market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 24 UNG market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 25 RNase inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 26 Bst polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 27 PCR master mix market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 28 Lyophilized polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 29 T7 RNA polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 30 Cas9 enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 31 Acid phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 32 Alanine aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 33 Alkaline phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 34 Amylase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 35 Angiotensin-converting enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 36 Aspartate aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 37 Cholinesterase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 38 Creatinine kinase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 39 Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 40 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 41 Renin market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 42 Glucose oxidase/Glucose dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 43 Urease market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 44 Lactate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 45 Horseradish peroxide market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 46 Glutamate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 47 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 48 Diagnostic enzymes market : Application outlook and key takeaways
  • FIG. 49 Diagnostic enzymes market: Application movement analysis
  • FIG. 50 Global diabetes prevalence data and forecast (numbers in million)
  • FIG. 51 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 52 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 53 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 54 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 55 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 56 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 57 Others market estimates and forecast, 2017-2030, USD Million
  • FIG. 58 Diagnostic enzymes market : Application outlook and key takeaways
  • FIG. 59 Diagnostic enzymes market: Product type movement analysis
  • FIG. 60 Molecular enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 61 Clinical enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 62 Diagnostic Enzymes Market: Regional outlook and key takeaways
  • FIG. 63 Diagnostic enzyme market: Regional movement analysis
  • FIG. 64 North America
  • FIG. 65 North America. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 66 U.S.
  • FIG. 67 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 68 Canada
  • FIG. 69 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 70 Europe
  • FIG. 71 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 72 UK
  • FIG. 73 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 74 Germany
  • FIG. 75 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 76 France
  • FIG. 77 France market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 78 Asia Pacific
  • FIG. 79 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 80 Japan
  • FIG. 81 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 82 China
  • FIG. 83 China. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 84 India
  • FIG. 85 India. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 86 Rest of World
  • FIG. 87 Rest of world market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 88 Brazil
  • FIG. 89 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 90 South Africa
  • FIG. 91 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 92 Ansoff Matrix
  • FIG. 93 Strategy mapping
  • FIG. 94 Company market share analysis, 2021
  • FIG. 95 Company market position analysis
  • FIG. 96 Company market position analysis
  • FIG. 97 Heat Map Analysis
  • FIG. 98 Market differentiators
  • FIG. 99 Heat Map Analysis
  • FIG. 100 Regional Network Map